ADx NeuroSciences

Industry / private company


Location: Gent, Belgium (BE) BE

ISNI: -

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

First amyloid β1-42 certified reference material for re-calibrating commercial immunoassays (2020) Boulo S, Kuhlmann J, Andreasson U, Brix B, Venkataraman I, Herbst V, Rutz S, et al. Journal article The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review (2018) Hansson O, Mikulskis A, Fagan AM, Teunissen C, Zetterberg H, Vanderstichele H, Molinuevo JL, et al. Journal article CSF Aβ1-42- an excellent but complicated Alzheimer's biomarker - a route to standardisation (2017) Kuhlmann J, Andreasson U, Pannee J, Bjerke M, Portelius E, Leinenbach A, Bittner T, et al. Journal article Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic (2017) O'Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, Lewczuk P, et al. Journal article Assessing the commutability of reference material formats for the harmonization of amyloid-? measurements (2016) Bjerke M, Andreasson U, Kuhlmann J, Portelius E, Pannee J, Lewczuk P, Umek RM, et al. Journal article A Practical Guide to Immunoassay Method Validation (2015) Andreasson U, Perret-Liaudet A, Van Doorn LJCVW, Blennow K, Chiasserini D, Engelborghs S, Fladby T, et al. Journal article